2019
Dave Ricks says Eli Lilly originated the $35 out-of-pocket cap on insulin, starting it in 2019 in the employer market.
“Actually, Lilly invented that. We started doing that in 2019 for the markets where we could, which is the employer market.”
Topic
Dave Ricks is the CEO of Eli Lilly, and this page collects what he said on podcasts including Cheeky Pint and Fortune's Leadership Next, covering GLP-1 drugs, why new medicines take so long to develop, and the business of pharma. Ricks said he is the 11th CEO in the company's roughly 150-year history.
Ricks told Leadership Next that drug development across the industry takes 13 or 14 years and that Lilly has cut its own times roughly in half. He also said tirzepatide reduces body weight by about 20 percent on average, and that Americans pay about 3 percent of hospital costs out of pocket but about 20 percent of pharmacy costs.
17 facts from 2 episodes, in date order. These are what speakers said on the shows, each linked to the moment it was said. They aren't independently verified.
2019
Dave Ricks says Eli Lilly originated the $35 out-of-pocket cap on insulin, starting it in 2019 in the employer market.
“Actually, Lilly invented that. We started doing that in 2019 for the markets where we could, which is the employer market.”
Undated
Dave Ricks says drug development across the pharmaceutical industry takes 13 or 14 years in total, and most Eli Lilly scientists never work on a successful drug in their careers.
“In total, in the industry, that takes 13 or 14 years. Most of our scientists, the thousands of people who work here, actually never work on something that's successful in their whole career.”
Undated
Dave Ricks says Eli Lilly has cut its drug development times roughly in half and fails faster than other companies.
“we've cut our times in roughly half. So we're failing a lot faster than others.”
Undated
Dave Ricks says he spends roughly 25 to 30 percent of his time working with Eli Lilly's scientific team.
“I probably spend, I don't know, 25, 30 % of my time working with the scientific team”
Undated
Dave Ricks predicts machine-aided drug discovery and development will be the standard approach in about ten years.
“machine-aided drug development and drug discovery, I think, in 10 years would be the way.”
Undated
Dave Ricks says Americans on average pay about 3 percent of hospital costs out of pocket but about 20 percent of pharmacy costs.
“So if you go to the hospital, we pay 3 % of that cost out-of-pocket in the US on average. If we go to the pharmacy, we pay 20 % out-of-pocket.”
Undated
Dave Ricks says about a billion people worldwide, including 100 million Americans, are overweight or have obesity.
“a billion people on planet earth have obesity overweight that's a lot 100 million americans”
Undated
Dave Ricks estimates that about 40 percent of US healthcare spending is tied to obesity.
“Maybe 40 % of US healthcare spending is tied to obesity.”
Undated
Dave Ricks says tirzepatide reduces body weight by about 20 percent on average.
“And so it's really helping reduce weight on average 20 % of body weight.”
Undated
Dave Ricks says that in Lilly's clinical trials, people on strict diet and exercise regimens lost at most about 5 percent of body weight after a year.
“we put people on strict diets and exercise. and after about a year, they lose about 5 % at most of their body weight.”
Undated
Dave Ricks says US taxpayers do not currently pay for obesity drugs because the government does not reimburse them, though about half of commercial payers do.
“In the U.S., it's important to note that taxpayers are bearing none of the cost. The U.S. doesn't reimburse these.”
Undated
Dave Ricks says he spent time running Eli Lilly's Canadian business and lived in Canada.
“I spent some time running our Canadian business and lived there.”
Undated
Dave Ricks says many telehealth visits allowed during the pandemic were later cut, which he regards as a loss of efficiency.
“we allowed for a lot of telehealth visits during the pandemic Those then got cut.”
Undated
Dave Ricks cites Eli Lilly's latest Alzheimer's drug as an example of progress against neurodegenerative disease.
“Our latest Alzheimer's drug, Kassanla, is an example of that.”
Undated
Dave Ricks says Lilly and others might have good non-opioid pain drugs in five to seven years.
“that maybe in five to seven years, we could have good pain drugs that can alleviate the need for opioids.”
Undated
Dave Ricks says the biggest change behind rising obesity over 40 years is processed foods, more than exercise or quantity of food.
“That's a little bit true, but the biggest thing that's changed is processed foods.”
Undated
Dave Ricks said he is the 11th CEO of Eli Lilly in its roughly 150-year history.
“And I'm the 11th CEO of the company. That's one less than Pope's in that period of time.”
Episodes